Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The functions and potential roles of extracellular vesicle noncoding RNAs in gynecological malignancies. | Cell Death Discov | 2021 | 34552067 | PubTator, text mining | PubMed |
| Transcriptomic Drivers of Differentiation, Maturation, and Polyploidy in Human Extravillous Trophoblast. | Front Cell Dev Biol | 2021 | 34540826 | PubTator, text mining | PubMed |
| The effective function of circular RNA in colorectal cancer. | Cancer Cell Int | 2021 | 34535136 | PubTator, text mining | PubMed |
| Comprehensive Analysis of E2F Family Members in Human Gastric Cancer. | Front Oncol | 2021 | 34532281 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma. | J Healthc Eng | 2021 | 34531966 | PubTator, text mining | PubMed |
| CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5p. | Onco Targets Ther | 2021 | 34531664 | PubTator, text mining | PubMed |
| PUM1 represses CDKN1B translation and contributes to prostate cancer progression. | J Biomed Res | 2021 | 34531333 | PubTator, text mining | PubMed |
| Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter. | Cancer Commun (Lond) | 2021 | 34523267 | PubTator, text mining | PubMed |
| Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer. | Nat Commun | 2021 | 34521849 | PubTator, text mining | PubMed |
| E2F transcription factor 1 (E2F1) promotes the transforming growth factor TGF-β1 induced human cardiac fibroblasts differentiation through promoting the transcription of CCNE2 gene. | Bioengineered | 2021 | 34521301 | PubTator, text mining | PubMed |
| Neurotoxicity of a pyrethroid pesticide deltamethrin is associated with the imbalance in proteolytic systems caused by mitophagy activation and proteasome inhibition. | Toxicol Appl Pharmacol | 2021 | 34520793 | PubTator, text mining | PubMed |
| Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease. | Front Cell Dev Biol | 2021 | 34513839 | PubTator, text mining | PubMed |
| E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B. | Mol Ther Nucleic Acids | 2021 | 34513297 | PubTator, text mining | PubMed |
| NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential. | Int J Biol Sci | 2021 | 34512157 | PubTator, text mining | PubMed |
| Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer. | Nat Commun | 2021 | 34508104 | PubTator, text mining | PubMed |
| The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung. | J Oncol | 2021 | 34504528 | PubTator, text mining | PubMed |
| [Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3. | Oncol Rep | 2021 | 34498717 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling. | Front Oncol | 2021 | 34490084 | PubTator, text mining | PubMed |
| Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis. | BMC Cancer | 2021 | 34488675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=48